Abstract
Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with persisting mixed chimerism (MC) among 231 patients transplanted with partially T cell-depleted stem cell grafts from HLA-identical siblings. Persisting MC is defined as MC for more than 2 years in patients without any evidence of relapse. Median leukemia-free survival in these patients was 150 (range, 50–218) months. Diagnoses were ALL (n = 10); AML (n = 2); CML (n = 2); NHL (n = 2); MDS (n = 1); MM (n = 1) and SAA (n = 1). Purpose of this study was the long-term follow-up of MC and definition of patterns of chimerism in the various subsets of PBMCs and granulocytes. Using a PCR-STR technique CD3+/CD4+ (T4 lymphocytes), CD3+/CD8+ (T8 lymphocytes), CD45+/CD19+ (B lymphocytes), CD45+/CD14+ (monocytes), CD45+/CD15+ (granulocytes) and CD3−/CD56+ (NK-cells) were analyzed. The majority of patients with persisting MC were conditioned with a less intensive conditioning regimen and had little GVHD. Sequential monitoring of the chimerism resulted in a group of patients (n = 7) with very slow transient mixed chimerism that resulted in complete DC after median 7 years. Another nine patients had a relatively high percentage of persisting autologous cells for a median of 12 years and in three patients we observed a stable low percentage of autologous cells. Only two out of 19 patients (AML-CR1, CML-CP1) relapsed during follow-up. Both patients had a relatively high percentage of autologous cells. Chimerism in granulocytes and PBMC subsets was analyzed at a median of 8 years after SCT in nine patients. In five patients mixed chimerism simultaneously detected by RCP and CYT was associated with MC in all subsets. Within each individual patient the percentages of donor and recipient cells were very different between the different subsets. Two CML-CP1 patients were mixed chimera in only two subsets and in one patient these subsets represented pending relapse. In another two patients mixed chimerism with a very low number of autologous red cells was not found in the PBMCs because of the different sensitivity level of the RCP and the PCR-STR technique. We conclude that in patients with persisting mixed chimerism after partially T cell-depleted SCT a remarkable number of patients had lymphoid malignancies, the majority of the patients were conditioned with less intensive conditioning regimens and the mixed chimerism was not correlated with relapse. Chimerism in granulocytes and PBMC subsets did show great intra-individual differences in the subsets and these data correlated well with RCP and CYT data with the exception of the NK cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Blazar BR, Orr HT, Arthur DC, Kersey JH, Filipovich AH . Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation Blood 1985 66: 1436–1444
Lo YM, Noakes L, Roux E, Jeannet M, Chapuis B, Flemming KA, Wainscoat JS . Application of a polymorphic Y microsatellite to the detection of post bone marrow transplantation chimaerism Br J Haematol 1995 89: 645–649
Ugozzoli L, Yam P, Petz LD, Ferrara GB, Champlin RE, Forman SJ, Koyal D, Wallace RB . Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation Blood 1991 77: 1607–1615
Schaap N, Schattenberg A, Bär B, Preijers F, Geurts van Kessel A, van der Maazen R, de Boo T, de Witte T . Outcome of transplantation for standard risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen Br J Haematol 1997 98: 750–759
Bär B, Schattenberg A, De Man A, Hoogenhout M, Boezeman J, Witte T . Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow Bone Marrow Transplant 1992 10: 45–52
Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, O'Reily RJ . Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response? Bone Marrow Transplant 1995 15: 591–594
van Leeuwen JE, van Tol MJ, Joosten AM, Schellekens PT, van den Berg RL, Waaijer JL, Oudeman-Gruber NJ, van der Weijden-Ragas CP, Roos MT, Gerritsen EJ . Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency Blood 1994 84: 3936–3947
Bertheas MF, Lafage M, Levy P, Blaise D, Stoppa AM, Viens P, Mannoni P, Maraninchi D . Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia Blood 1991 78: 3103–3106
Roy DC, Tantravahi R, Murray C, Dear K, Gorgone B, Anderson KC, Friedman AS, Nadler LM, Ritz J . Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium Blood 1990 75: 296–304
Lawler M, Humphries P, McCann SR . Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction Blood 1991 77: 2504–2514
Briones J, Urbano Ispizua A, Lawler M, Rozman C, Gardiner N, Marin P, Salgado C, Feliz P, McCann S, Montserrat E . High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells Exp Hematol 1998 26: 415–420
Martin PJ . Determinants of engraftment after allogeneic marrow transplantation (editorial) Blood 1992 79: 1647–1650
Martinelli G, Trabetti E, Zaccaria A, Farabegoli P, Buzzi M, Testoni N, Calori E, Bandini G, Rosti G, Belardinelli, Gasparini P, Galavotti R, Ambrosetti A, Tura S, Pignatti PF . In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic BMT Bone Marrow Transplant 1993 12: 115–120
Offit K, Burns JP, Cunningham I, Jhanwar SC, Black P, Kernan Na, O'Reilly RJ, Chaganti RS . Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation Blood 1990 75: 1346–1355
Petz LD, Yam P, Wallace RB, Stock AD, de Lange G, Knowlton RG, Brown VA, Donis-Keller H, Hill LR, Forman SJ . Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies Blood 1987 70: 1331–1337
Elmaagacli AH, Becks HW, Beelen DW, Stockova J, Butzler R, Opalka B, Schaefer UW . Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia Bone Marrow Transplant 1995 16: 823–829
Petit T, Raynal B, Socie G, Landman-Parker J, Bourhis JH, Gluckman E, Pico J, Brison O . Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation Blood 1994 84: 3575–3583
Viard F, Merel P, Bilhou-Nabera C, Marit G, Comeau F, Gharbi MJ, Febrer F, Belloc F, Lacombe F, Broustet A, Vezon G, Reiffers J, Bernhard Ph . Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques Bone Marrow Transplant 1993 11: 27–31
Schattenberg A, de Witte T, Preijers F, Raemaekers J, Muus P, van der Lely N, Boezeman J, Wessels J, van Dijk B, Hoogenhout J, Haanen C . Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation Blood 1990 75: 1356–1363
de Witte T, Raymakers R, Plas A, Koekman E, Wessels J, Haanen C . Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation Transplantation 1984 37: 151–155
Plas A, de Witte T, Wessels H, Haanen C . A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials Exp Hematol 1988 16: 355–359
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED . Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Stord R, Thomas ED . Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204–217
Schattenberg A, de Witte T, Salden M, Vet J, van Dijk B, Smeets D, Hoogenhout J, Haanen C . Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse Blood 1989 73: 1367–1372
Schattenberg A, Bär B, Vet J, van Dijk B, Smeets D, de Witte T . Comparison of chimerism of red cells with that of granulocytes, T lymphocytes, and bone marrow cells in recipients of marrow depleted of lymphocytes using counterflow centrifugation Leuk Lymphoma 1991 5: 171–177
McCann SR, Lawler M . Mixed chimaerism; detection and significance following BMT Bone Marrow Transplant 1993 11: 91–94
Bär B, Schattenberg A, Van Dijk BA, de Man AJ, Kunst VA, de Witte T . Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analyzed with antibody-coated fluorescent microspheres Br J Haematol 1989 72: 239–245
De Man AJ, Foolen WJ, Van Dijk BA, Kunst VA, de Witte T . A fluorescent microsphere method for the investigation of erythrocyte chimaerism after allogeneic bone marrow transplantation using antigenic differences Vox Sang 1988 55: 37–41
Hendriks EC, De Man AJ, van Berkel YC, Stienstra S, de Witte T . Flow cytometric method for the routine follow-up of red cell populations after bone marrow transplantation Br J Haematol 1997 97: 141–145
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215
Higuchi R . Rapid, Efficient DNA Extraction for PCR from Cells or Blood. Amplifications: a Forum for PCR Users Perkin Elmer: Norwalk, CT 1989
Nuckols JD, Rasheed BK, McGlennen RC, Bigner SH, Stenzel TT . Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit Am J Clin Pathol 2000 113: 135–140
Frankel W, Chan A, Corringham RE, Shepherd S, Rearden A, Wang-Rodriguez J . Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats Am J Hematol 1996 52: 281–287
Oberkircher AR, Strout MP, Herzig GP, Fritz PD, Caligiuri MA . Description of an efficient and highly informative method for the evaluation of hematopoietic chimerism following allogeneic bone marrow transplantation Bone Marrow Transplant 1995 16: 695–702
Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA . Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers Blood 1995 85: 1954–1963
Roux E, Helg C, Dumont-Girard F, Chapuis B, Jeannet M, Roosnek E . Analysis of T cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T cell-depleted and unmanipulated grafts Blood 1996 87: 3984–3992
Socie G, Lawler M, Gluckman E, McCann SR, Brison O . Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era Leukemia Res 1995 19: 497–504
Bader P, Beck J, Frey A, Schlegel PG, Hebarth H, Handgretinger R, Einsele H, Niemeyer C, Benda N, Faul C, Kanz L, Niethammer D, Klingebiel T . Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT Bone Marrow Transplant 1998 21: 487–495
Bader P, Stoll K, Huber S, Geiselhart A, Handgretinger R, Niemeyer C, Einsele H, Schlegel PG, Niethammer D, Beck J, Klingebiel T . Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse Br J Haematol 2000 108: 761–768
McSweeney PA, Storb R . Mixed chimerism: preclinical studies and clinical applications Biol Blood Marrow Transplant 1999 5: 192–203
Bader P, Holle W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG, Niethammer D, Beck J . Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children Bone Marrow Transplant 1997 19: 697–702
Hancock JP, Burgess MF, Goulden NJ, Steward CG, Knechtli CJ, Pamphilon DH, Potter MN, Oakhill A . Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation Br J Haematol 1997 99: 403–409
Mackinnon S, Barnett L, Heller G, O'Reilly RJ . Minimal residual disease is more common in patients who have mixed T cell chimerism after bone marrow transplantation for chronic myelogenous leukemia Blood 1994 83: 3409–3416
Patri S, Dascalesu C, Chomel JC, Sadoun A, Lacotte L, Tanzer J, Guilhot F, Kitzis A . Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequences Bone Marrow Transplant 1996 17: 625–632
Ramirez M, Diaz MA, Garcia SF, Sanchez F, Velasco M, Casado F, Villa M, Vicario JL, Madero L . Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia Bone Marrow Transplant 1996 18: 1161–1165
Suttorp M, Schmitz N, Dreger P, Schaub J, Loffler H . Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms Leukemia 1993 7: 679–687
Molloy K, Goulden N, Lawler M, Cornish J, Oakhill A, Pamphilon D, Potter M, Steward C, Langlands K, Humphries P, McCann SR . Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors Blood 1996 87: 3027–3031
Bader P, Beck J, Schlegel PG, Handgretinger R, Niethammer D, Klingebiel T . Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic bmt in children with acute leukemia: is there an option to prevent relapse Bone Marrow Transplant 1997 20: 79–81
Schaap N, Schattenberg A, Bär B, Mensink E, de Man A, Geurts van Kessel A, de Witte T . Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T cell-depleted bone marrow transplantation and after donor leucocyte infusion Br J Haematol 2000 108: 116–125
Dermime S, Mavroudis D, Jiang YZ, Hensel N, Molldrem J, Barret AJ . Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 989–999
Sondel PM, Hank JA, Molenda J, Blank J, Borcherding W, Longo W, Trigg ME, Hong R, Bozdech MJ . Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the ‘graft versus leukemia’ effect Exp Hematol 1985 13: 782–790
Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jocobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H . Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Blood 1995 86: 2041–2050
Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM . Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity Blood 1994 84: 3261–3282
Mangioni S, Balduzzi A, Rivolta A, Rovelli A, Nesi F, Rossi V, Busca A, Uderzo C, Miniero R, Biondi A . Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation Bone Marrow Transplant 1997 20: 969–973
Dolstra H, Fredrix H, Maas F, Coulie PG, Brasseur F, Mensink E, Adema GJ, de Witte T, Figdor CG, van de Wiel van Kemenade E . A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia J Exp Med 1999 189: 301–308
van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Khan PM, Vossen JM . Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse Blood 1993 82: 1921–1928
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schaap, N., Schattenberg, A., Mensink, E. et al. Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation. Leukemia 16, 13–21 (2002). https://doi.org/10.1038/sj.leu.2402343
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402343
Keywords
This article is cited by
-
Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)
Bone Marrow Transplantation (2020)
-
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation
Leukemia (2020)
-
A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation
Annals of Hematology (2014)
-
Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation
Leukemia (2012)
-
Automated detection of residual cells after sex-mismatched stem-cell transplantation – evidence for presence of disease-marker negative residual cells
Molecular Cytogenetics (2009)